Glucose & Insulin: Understanding Metabolic Health
Insulin resistance is the silent engine behind metabolic syndrome, prediabetes, type 2 diabetes, polycystic ovary syndrome (PCOS), and non-alcoholic fatty liver disease. It affects an estimated 1 in 3 Australian adults, yet most cases go undiagnosed for years because standard glucose tests only catch the problem after significant damage has already occurred.
A fasting glucose test tells you where your blood sugar is right now. But fasting insulin and HOMA-IR reveal whether your pancreas is working overtime to keep that number normal. By the time glucose rises above 5.5 mmol/L, your body may have been silently resistant for 5–15 years. Understanding these markers early gives you the power to intervene when lifestyle changes are most effective — long before medication becomes necessary.
The Insulin Resistance Spectrum
Insulin resistance does not appear overnight. It develops along a spectrum over years to decades. The key insight is that insulin rises first, glucose rises last. Standard pathology panels that only measure glucose miss the earliest and most treatable stages entirely.
Normal
Cells respond efficiently to insulin. Glucose enters cells readily after meals. Pancreas produces just enough insulin to keep blood sugar in a tight range. HOMA-IR typically below 1.0.
Early Resistance
Muscle, liver and fat cells begin ignoring insulin’s signal. The pancreas compensates by producing MORE insulin to force glucose into cells. Fasting glucose looks fine, but fasting insulin is already high. This stage can last 5–15 years undetected.
Prediabetes
Pancreatic compensation is failing. Fasting glucose rises above 5.5 mmol/L (100 mg/dL) and HbA1c creeps into the 5.7–6.4% range. Beta cells are under chronic stress. Without intervention, 5–10% of people with prediabetes progress to type 2 diabetes each year.
Type 2 Diabetes
The pancreas can no longer keep up with demand. Fasting glucose exceeds 7.0 mmol/L (126 mg/dL) and HbA1c is 6.5% or above. Beta cell function may decline further over time, eventually requiring insulin therapy in some patients.
Reference Ranges — Glucose & Insulin Markers
Ranges based on RCPA (Royal College of Pathologists of Australasia), WHO, and ADA guidelines. “Optimal” targets are often tighter than laboratory reference ranges and reflect current metabolic health research.
| Marker | Normal | Borderline | Abnormal | US Equivalent |
|---|---|---|---|---|
| Fasting Glucose | 3.5 – 5.5 mmol/L | 5.6 – 6.9 mmol/L (IFG) | ≥ 7.0 mmol/L (diabetes) | 63 – 99 mg/dL | 100–125 | ≥126 |
| Random Glucose | < 7.8 mmol/L | 7.8 – 11.0 mmol/L | ≥ 11.1 mmol/L (diabetes) | < 140 mg/dL | 140–199 | ≥200 |
| HbA1c → | < 5.7% / < 39 mmol/mol | 5.7 – 6.4% / 39–47 | ≥ 6.5% / ≥ 48 mmol/mol | Same worldwide |
| Fasting Insulin | 2 – 12 mU/L (optimal < 10) | 12 – 20 mU/L | > 20 mU/L | Same units (mU/L = µIU/mL) |
| HOMA-IR | < 1.0 (optimal) | 1.0 – 1.9 (early resistance) | ≥ 2.0 (significant) / ≥ 3.0 (severe) | Same formula worldwide |
| C-Peptide (fasting) | 0.4 – 1.2 nmol/L | 1.2 – 1.5 nmol/L | > 1.5 nmol/L (insulin resistance) or < 0.2 (type 1) | 1.1 – 3.6 ng/mL |
| Fructosamine | 200 – 285 µmol/L | 286 – 330 µmol/L | > 330 µmol/L | Same units |
| OGTT 2-hour | < 7.8 mmol/L | 7.8 – 11.0 mmol/L (IGT) | ≥ 11.1 mmol/L (diabetes) | < 140 mg/dL | 140–199 | ≥200 |
Why Standard Tests Miss Insulin Resistance
Here is the fundamental problem: when cells become resistant to insulin, the pancreas simply makes more. If your pancreas is producing three times the normal amount of insulin, your fasting glucose will look perfectly normal on a blood test. The GP ticks the box, tells you everything is fine, and sends you home.
Meanwhile, chronically elevated insulin is driving visceral fat accumulation, raising triglycerides, lowering HDL cholesterol, increasing blood pressure, promoting inflammation, and exhausting your beta cells. This is the hyperinsulinaemic phase of metabolic disease, and it can persist for 5–15 years before glucose ever rises.
Testing fasting insulin alongside fasting glucose (and calculating HOMA-IR) catches this hidden stage. It is inexpensive, widely available, and arguably one of the most underutilised tests in preventive medicine. If your fasting insulin is above 10 mU/L or your HOMA-IR is above 1.5, your metabolism is already working harder than it should — even if every other number looks “normal”.
HOMA-IR Explained
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is the most widely used research tool for estimating insulin resistance from a simple fasting blood test. It was developed by Matthews et al. in 1985 and remains the clinical standard.
Both values must be measured from the same fasting blood draw (minimum 8 hours fasting). HOMA-IR is not a diagnostic test on its own but is an excellent screening tool that adds crucial context when interpreted alongside glucose and HbA1c.
Optimal
Excellent insulin sensitivity. Cells respond efficiently to insulin. Low risk of metabolic disease.
Early Resistance
Mild insulin resistance developing. Lifestyle intervention at this stage is highly effective. Consider diet, exercise and weight management.
Significant Resistance
Moderate-to-significant insulin resistance. Metabolic syndrome features likely present. Aggressive lifestyle changes recommended. Monitor HbA1c every 6 months.
Severe Resistance
Severe insulin resistance. High risk of progression to type 2 diabetes. Pharmacological intervention (e.g. metformin) may be warranted alongside lifestyle changes.
Metabolic Syndrome Criteria (IDF Definition)
Metabolic syndrome is diagnosed when central obesity is present plus any two of the following criteria. It affects approximately 30% of Australian adults and dramatically increases the risk of type 2 diabetes, heart disease, and stroke.
| Criterion | Men | Women |
|---|---|---|
| Waist circumference (Europid) | ≥ 94 cm | ≥ 80 cm |
| Triglycerides | ≥ 1.7 mmol/L (150 mg/dL) | ≥ 1.7 mmol/L (150 mg/dL) |
| HDL cholesterol | < 1.03 mmol/L (40 mg/dL) | < 1.29 mmol/L (50 mg/dL) |
| Blood pressure | ≥ 130/85 mmHg | ≥ 130/85 mmHg |
| Fasting glucose | ≥ 5.6 mmol/L (100 mg/dL) | ≥ 5.6 mmol/L (100 mg/dL) |
Central obesity (waist circumference) is the required criterion. Ethnicity-specific cutoffs apply: South Asian/Chinese \u2265 90 cm (men) / \u2265 80 cm (women); Japanese \u2265 85 cm (men) / \u2265 90 cm (women). See Cholesterol & Lipids → for detailed triglyceride and HDL interpretation.
Who Should Request Insulin Resistance Testing?
The RACGP recommends diabetes screening from age 40 (or age 18 for Aboriginal and Torres Strait Islander peoples). However, if you have any of the following risk factors, requesting fasting insulin and HOMA-IR in addition to standard glucose testing is strongly recommended.
Overweight or obese (BMI ≥ 25, or ≥ 23 for Asian populations)
Family history of type 2 diabetes (first-degree relative)
Polycystic ovary syndrome (PCOS) — insulin resistance is a core driver
History of gestational diabetes (50% lifetime risk of type 2 diabetes)
Age over 40 with any additional risk factor
Acanthosis nigricans (dark, velvety skin patches on neck, armpits, or groin)
Non-alcoholic fatty liver disease (NAFLD) or elevated liver enzymes
Sedentary lifestyle with central adiposity (waist circumference above thresholds)
Aboriginal and Torres Strait Islander peoples (screen from age 18)
South Asian, Middle Eastern, or Pacific Islander ethnicity (higher genetic risk)
Improving Insulin Sensitivity
The good news: insulin resistance is highly reversible with lifestyle changes, especially when caught early. The Finnish Diabetes Prevention Study demonstrated a 58% reduction in diabetes progression with diet and exercise alone — more effective than metformin.
Improves Sensitivity
Resistance training
Builds muscle mass, increasing glucose disposal sites. Even 2–3 sessions per week can reduce HOMA-IR by 20–30%.
HIIT exercise
High-intensity interval training improves insulin sensitivity within days. 15–20 minutes, 3 times per week is sufficient.
Weight loss (5–10%)
Losing just 5% of body weight reduces visceral fat and improves hepatic insulin sensitivity. The Finnish DPS showed 58% diabetes risk reduction.
Dietary fibre
Aim for 25–30g/day. Soluble fibre (oats, legumes, psyllium) slows glucose absorption and improves postprandial insulin response.
Quality sleep (7–9 hours)
Even one night of poor sleep reduces insulin sensitivity by 25–30%. Consistent sleep schedule matters more than total hours.
Time-restricted eating
Eating within an 8–10 hour window allows insulin levels to fall, promoting metabolic flexibility and reducing fasting insulin.
Worsens Resistance
Refined carbohydrates
White bread, pastries, sugary cereals cause rapid glucose spikes that drive compensatory hyperinsulinaemia and worsen resistance over time.
Sugary drinks
A single 600mL soft drink contains ~16 teaspoons of sugar. Regular consumption increases type 2 diabetes risk by 26% (meta-analysis).
Sedentary lifestyle
Prolonged sitting reduces GLUT4 transporter activity. Breaking up sitting every 30 minutes improves postprandial glucose by 20–40%.
Chronic stress
Cortisol directly opposes insulin action, raising blood sugar and promoting visceral fat deposition. Address with meditation, exercise or therapy.
Poor sleep
Short sleep (≤ 5 hours) and irregular schedules impair glucose tolerance through cortisol, ghrelin and sympathetic nervous system activation.
Excess alcohol
While moderate red wine may have mild benefit, heavy drinking causes hepatic insulin resistance, fatty liver and impaired gluconeogenesis regulation.
Related Blood Test Guides
When to See Your Doctor
This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment decisions.
Track Your Glucose & Metabolic Markers Over Time
Upload your blood test results and watch your fasting glucose, insulin, HOMA-IR and HbA1c trend on interactive charts. See how diet, exercise and lifestyle changes translate into measurable metabolic improvements — free forever for the first million users.
Get Started FreeMedical Disclaimer: The information on this page is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis or treatment. Reference ranges may vary between laboratories and individual circumstances. Always discuss your blood test results with a qualified healthcare professional who understands your complete medical history.